Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYBB | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SLC22A18 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | ICA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | DNAJB9 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | CT45A3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | AKAP2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | ERICH5 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | RUFY2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | TBC1D7 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | SLC16A14 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |